<p>The UK is committed to rapid equitable access to safe and effective vaccines. We are among the largest bilateral contributors to the COVAX Advance Market Commitment (AMC), committing £548 million in 2020 to support vaccinations in low and middle-income countries. Our contribution included a match funding pledge that helped encourage $1 billion of commitments from other donors.</p><p>From February 2021, COVAX AMC participants have received vaccines as their National Deployment and Vaccination Plans (NDVPs) are assessed as ready to receive and deploy vaccines. The UK's support and contribution to COVAX has helped it reach its milestone to supply vaccines to over 100 countries and economies.</p>